The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Kim, Jong Man ^a   Kwon, Choon Hyuck David ^a   Joh, Jae Won ^a   Park, Jae Berm ^a   Ko, Justin Sangwook ^a   Lee, Joon Hyeok ^a   Kim, Sung Joo ^a   Park, Cheol Keun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Liver resection; Metastasis; Survival

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; AGED; ARTICLE; ASCITES; ATELECTASIS; BACTERIAL PERITONITIS; BILE LEAKAGE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; DELIRIUM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYPERBILIRUBINEMIA; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; PORTAL VEIN THROMBOSIS; RETROSPECTIVE STUDY; SURGICAL INFECTION; SURGICAL MORTALITY; WOUND DEHISCENCE;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84874013376     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-40     Document Type: Article

References (34)

1. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg 2004, 91:322-326. 10.1002/bjs.4413, 14991633.
2. Choi GH, Han DH, Kim DH, Choi SB, Kang CM, Kim KS, Choi JS, Park YN, Park JY, Kim do Y. Outcome after curative resection for a huge (≥ 10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg 2009, 198:693-701. 10.1016/j.amjsurg.2008.09.019, 19268907.
3. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007, 14:2817-2823. 10.1245/s10434-007-9518-1, 17690940.
4. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000, 73:109-114. 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J, 10694648.
5. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005, 11:1086-1092. 10.1002/lt.20472, 16123959.
6. Poon RT, Fan ST, O'Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002, 195:311-318. 10.1016/S1072-7515(02)01226-7, 12229937.
7. Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, DeMatteo RP. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer 2005, 104:1948-1955. 10.1002/cncr.21415, 16196045.
8. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 2004, 85:36-41. 10.1002/jso.10284, 14696085.
9. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006, 202:275-283. 10.1016/j.jamcollsurg.2005.10.005, 16427553.
10. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005, 25:181-200. 10.1055/s-2005-871198, 15918147.
11. Liu CL, Fan ST, Lo CM, Tung-Ping Poon R, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg 2000, 232:25-31. 10.1097/00000658-200007000-00004, 1421104, 10862191.
12. Liver Cancer Study Group of Japan General rules for the clinical and pathological study of primary liver cancer 2003, Tokyo: Kanehara & Co., 2, Liver Cancer Study Group of Japan.
13. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503. 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E, 13160935.
14. Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol 2003, 10:1070-1076. 10.1245/ASO.2003.03.072, 14597446.
15. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002, 47:389-399.
16. Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am 2003, 12:35-50. viii, 10.1016/S1055-3207(02)00086-8, 12735128.
17. Mok KT, Wang BW, Lo GH, Liang HL, Liu SI, Chou NH, Tsai CC, Chen IS, Yeh MH, Chen YC. Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg 2003, 197:730-738. 10.1016/j.jamcollsurg.2003.07.013, 14585406.
18. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007, 94:320-326. 10.1002/bjs.5622, 17205495.
19. Nagano Y, Tanaka K, Togo S, Matsuo K, Kunisaki C, Sugita M, Morioka D, Miura Y, Kubota T, Endo I. Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg 2005, 29:66-71. 10.1007/s00268-004-7509-y, 15599739.
20. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002, 20:1527-1536. 10.1200/JCO.20.6.1527, 11896101.
21. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. 10.1002/hep.20933, 16250051.
22. Blumgart LH, Leach KG, Karran SJ. Observations on liver regeneration after right hepatic lobectomy. Gut 1971, 12:922-928. 10.1136/gut.12.11.922, 1411942, 5132225.
23. Miyagawa S, Kawasaki S, Noike T, Nomura K, Kobayashi A, Shimada R, Imamura H. Liver regeneration after extended right hemihepatectomy in patients with hilar or diffuse bile duct carcinoma. Hepatogastroenterology 1999, 46:364-368.
24. Yamashita Y, Taketomi A, Shirabe K, Aishima S, Tsuijita E, Morita K, Kayashima H, Maehara Y. Outcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter). J Surg Oncol 2011, 104:292-298. 10.1002/jso.21931, 21465490.
25. Chen WT, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 2004, 30:414-420. 10.1016/j.ejso.2004.01.013, 15063895.
26. Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, Joh JW, Kim YI. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004, 230:135-141. 10.1148/radiol.2301021182, 14631050.
27. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999, 229:216-222. 10.1097/00000658-199902000-00009, 1191634, 10024103.
28. Tarao K, Rino Y, Takemiya S, Tamai S, Ohkawa S, Sugimasa Y, Miyakawa K, Morinaga S, Yoshida M, Shibuya A. Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 2000, 43:20-26. 10.1159/000025019, 10773734.
29. Moriyama M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Goto I, Tanaka N, Arakawa Y. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Liver Int 2005, 25:85-90. 10.1111/j.1478-3231.2005.01028.x, 15698403.
30. Taketomi A, Takenaka K, Matsumata T, Shimada M, Higashi H, Shirabe K, Itasaka H, Adachi E, Maeda T, Sugimachi K. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection. Hepatogastroenterology 1997, 44:477-483.
31. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, Shiomi S, Tamori A, Oka H, Igawa S. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized controlled trial. Ann Intern Med 2001, 134:963-967.
32. Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye QH, Zhang BH, Qian YB, Wu ZQ, Fan J. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol 2006, 132:458-465. 10.1007/s00432-006-0091-y, 16557381.
33. Chen CH, Hu FC, Huang GT, Lee PH, Tsang YM, Cheng AL, Chen DS, Wang JD, Sheu JC. Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - analysis of 2,010 Taiwanese patients. Eur J Cancer 2009, 45:1630-1639. 10.1016/j.ejca.2008.12.025, 19157858.
34. Tong MJ, Chavalitdhamrong D, Lu DS, Raman SS, Gomes A, Duffy JP, Hong JC, Busuttil RW. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J Clin Gastroenterol 2010, 44:e63-e70. 10.1097/MCG.0b013e3181b4b68b, 19745756.